(Q64042639)

English

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Dutasteride (0.5mg) Once Daily for One Year and Tamsulosin (0.4mg) Once Daily for 3 Months, Followed by Counseling on Flex Dose Tamsulosin as Needed on Improvement of Symptoms and Outcome in Men With Moderate to Severe Symptomatic BPH (English)

0 references

medical condition

hyperplasia

0 references

country

United States of America

0 references

contributor to the creative work or subject

GSK

0 references

start time

September 2005

0 references

end time

July 2009

0 references

number of participants

63

0 references

research intervention

tamsulosin

0 references

clinical trial phase

phase IV clinical trial

0 references

minimum age

50 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00701779

0 references

(Q64042639)

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)